Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine PCIA vs sufentanil after mastectomy
ChiCTR2600124027Phase 4Not yet recruiting
- Sponsor
- The Sixth Affiliated Hospital, South China University of Technology
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in postoperative pain (2 arms), sponsored by The Sixth Affiliated Hospital, South China University of Technology. Primary endpoint: Quality of recovery-15 (QoR-15) score. Planned start May 2026; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600124027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124027.